A workplace cannabis policy is the written rule that sets out how an employer handles cannabis in relation to work: what is prohibited, how impairment is assessed, how testing is used, and how an employee holding a prescription is treated. In South Africa the ground under these policies moved in 2024, when the Labour Appeal Court found that dismissing an office-based employee for off-duty cannabis use, under a blanket zero-tolerance rule and with no evidence of impairment, amounted to unfair discrimination. A workplace cannabis policy written before that ruling is very likely out of date.
Last updated:
Key takeaways
- A blanket zero-tolerance rule applied identically to every role is now the riskiest position an employer can take, not the safest.
- In Enever v Barloworld Equipment the Labour Appeal Court found the dismissal automatically unfair and awarded compensation equal to 24 months of pay, because there was no clear safety risk and no evidence of impairment.
- A urine test detects a metabolite that can persist for weeks. It is evidence of past use, not evidence of being impaired at work, and a policy that treats the two as the same thing is hard to defend.
- Risk should be graded by role. A safety-critical job and a desk job genuinely do not carry the same consequence, and a defensible policy says so in writing.
- An employee using a prescribed cannabis medicine is in a different category again, closer to any other prescribed medicine that can affect alertness.
- This article is general information, not legal advice. Have your policy reviewed by a South African labour lawyer before you rely on it.
What must a workplace cannabis policy actually cover?
A workplace cannabis policy has to answer four separate questions, and most weak policies collapse them into one. The questions are: what conduct is prohibited and where, how impairment will be identified, what role testing plays and what a positive result means, and how the employer will treat an employee who has a valid prescription.
Collapsing those into a single line that says cannabis use is prohibited and a positive test means dismissal is what produces litigation. It prohibits something the employer may have no lawful interest in, which is private conduct at home, while saying nothing useful about the thing the employer does have a legitimate interest in, which is whether someone is fit to do their job safely today.
The useful mental model is that an employer is regulating work, not private life. Private adult use in a private place was decriminalised following the Constitutional Court judgment in the Prince matter in 2018, and the framework for it now sits in the Cannabis for Private Purposes Act 7 of 2024. An employer does not get to reverse that by contract. What an employer can legitimately require is that an employee arrives fit for duty and stays that way.
What the Enever judgment changed for South African employers
Bernadette Enever was dismissed by Barloworld Equipment after testing positive for cannabis that she had used after hours, in private. The dismissal rested on the company policy of zero tolerance towards drug use. She argued that she had consumed cannabis at home and was not impaired at work.
The Labour Appeal Court found that the dismissal was automatically unfair and amounted to unfair discrimination, and awarded her compensation equivalent to 24 months of remuneration. The reasoning that matters for policy drafting is why. The court took into account that there was no clear safety risk in her role and no evidence of impairment or danger to the employer. A rule applied uniformly, regardless of whether the job was safety-critical and regardless of whether anyone was actually impaired, could not be justified.
Two practical conclusions follow. The first is that uniformity is not a defence. A policy that treats a site foreman operating machinery and an accounts clerk identically is not being even-handed, it is failing to distinguish between materially different situations. The second is that the employer carries the burden of showing a real, job-related risk. Asserting that cannabis is dangerous in general does not discharge that burden for a specific role.
Impairment is the test, not the presence of a metabolite
This is the technical point that policies most often get wrong, and it is worth being precise about. Standard urine screening does not measure impairment. It detects THC-COOH, an inactive metabolite that the body clears slowly and which can remain detectable for days after occasional use and considerably longer in a frequent user. A positive urine result is therefore evidence that someone used cannabis at some point in a window that may extend well beyond the last shift.
Alcohol testing conditioned a generation of managers to expect otherwise, because a breathalyser reading correlates reasonably well with current impairment. No equivalent roadside-style measure exists for cannabis. That mismatch is the whole problem: the available test answers a question about the past, while the policy needs an answer about the present.
The workable response is to treat testing as one input rather than as the verdict. Observed and recorded indicators of impairment, such as coordination, coherence, reaction and behaviour witnessed by a trained supervisor, carry the weight. A test result can corroborate. Where a role is genuinely safety-critical, an employer can reasonably set a stricter fitness-for-duty standard, but the policy should say which roles those are and why. The national picture behind those workplace rules is in our guide to medical cannabis policy, which covers the costs patients carry and where access still falls short.
Before you start
In South Africa, cannabis containing THC is prescription-only through a registered doctor, usually via a SAHPRA section 21 authorisation where the product is unregistered. This article is general information for adults aged 18 and over. It is not legal advice and it is not medical advice. Employers should have any policy reviewed by a labour lawyer, and employees should take any question about a prescribed medicine and its effect on their work to the prescribing doctor or a pharmacist.
Grading risk by role rather than applying one rule
Grading is the part that turns a slogan into a defensible document. The table below is a way of structuring the thinking rather than a template to copy, because the correct categories depend on what your organisation actually does.
| Role category | Example | Proportionate approach |
|---|---|---|
| Safety-critical | Operating machinery, driving, working at height, mining | Strict fitness-for-duty standard, documented justification for the role, testing regime explained in advance |
| Safety-sensitive | Clinical care, childcare, handling hazardous substances | Impairment-led assessment with a clear escalation route and supervisor training |
| Non-safety-critical | Administrative, desk-based and most office work | Conduct and performance standards only; off-duty private use is not the employer concern |
| Employee with a prescription | Any role, where a doctor has prescribed a cannabis medicine | Treat as any prescribed medicine affecting alertness: confidential disclosure, fitness assessment, reasonable adjustment where practicable |
How to handle an employee with a prescription
This is the situation employers feel least prepared for, and it is becoming more common as legal access widens. The starting point is that a prescribed cannabis medicine is a prescribed medicine. Plenty of lawfully prescribed drugs affect alertness, and most organisations already have a way of dealing with that. The answer is to use the existing pathway rather than to invent a separate and harsher one for cannabis.
In practice that means a confidential disclosure route that does not run through the line manager by default, an occupational health assessment focused on fitness for the specific duties rather than on the diagnosis, and consideration of reasonable adjustment where the role allows it. Health information is sensitive personal information, so it should be held by the people who need it and no one else.
Employers should also know what the legal route looks like, because it affects what an employee can reasonably be asked to produce. A cannabis medicine containing THC requires a prescription from a registered doctor, and where the product is not registered in South Africa the doctor applies to SAHPRA under section 21 of the Medicines and Related Substances Act 101 of 1965 for a named patient, a specified quantity and a specified period. An employee on that route has documentation. Asking to see the prescription detail, rather than the underlying diagnosis, is usually the proportionate request. Understanding how a prescribed product is documented and traced helps managers tell a legitimate medicine apart from an informal purchase.
What a defensible workplace cannabis policy contains
Pulling the above together, a workplace cannabis policy that is likely to survive scrutiny tends to share the same skeleton. It states its purpose as workplace safety and fitness for duty rather than as disapproval of cannabis. It defines impairment and explains how it will be observed and recorded. It lists which roles are treated as safety-critical and gives the operational reason for each, rather than asserting the category.
It explains what testing is used, when, what the test can and cannot show, and that a positive result triggers a process rather than an automatic outcome. It sets out the disciplinary process, including the right to respond. It provides a confidential route for disclosing a prescribed medicine and commits to assessing fitness rather than to excluding people. It is communicated to staff before it is enforced, and it is applied consistently once it is.
The underlying statutory duty has not changed. The Occupational Health and Safety Act 85 of 1993 requires an employer to provide and maintain a working environment that is safe and without risk to health, so far as is reasonably practicable. That duty is what justifies a fitness-for-duty standard. It is not a licence to police private conduct that has no bearing on the work.
How Professor Green fits into the process
Professor Green is a South African medical cannabis access platform and a marketing affiliate of the Dr Green network, which holds the medical cannabis licences. Professor Green does not itself sell, handle or ship cannabis. Products are sold and fulfilled by the licensed operator, and every regulated step stays with the party licensed to perform it.
Professor Green does not advise employers, write policies, or verify anyone’s employment status, and registering an account has no bearing on an employment matter. What registering does is create an account and open the store-access area so an individual can see how the prescriber-led route is organised. Whether a cannabis-based medicine is appropriate for someone is a clinical decision made by a registered doctor, and whether a particular workplace rule is lawful is a question for a labour lawyer.
The reason this article exists is that the two questions get tangled together constantly. An employee who has been through a documented medical route is in a very different position from someone who has not, and a policy that cannot tell those situations apart will treat them identically and get it wrong.
Frequently asked questions
Can a South African employer still have a zero-tolerance drug rule?
An employer can set a strict fitness-for-duty standard, but applying a single blanket rule identically to every role is what the Labour Appeal Court found could not be justified in Enever v Barloworld Equipment. The rule needs to be tied to a real, job-related risk.
Does a positive cannabis test prove an employee was impaired at work?
No. Standard urine screening detects an inactive metabolite that can remain in the body for days or weeks after use. It shows past use, not current impairment, which is why it should support an impairment assessment rather than replace it.
What happened in Enever v Barloworld Equipment?
An employee was dismissed after testing positive for cannabis she had used off duty at home, under a zero-tolerance policy. The Labour Appeal Court found the dismissal automatically unfair and discriminatory, noting the absence of a clear safety risk or evidence of impairment, and awarded compensation equal to 24 months of remuneration.
Can an employee be required to disclose a cannabis prescription?
A policy can require disclosure of any medicine that may affect fitness for duty, handled confidentially. The proportionate request is usually for the prescription detail relevant to fitness, not the underlying diagnosis, and health information is sensitive personal information.
Does decriminalisation mean cannabis is allowed at work?
No. Private adult use in a private place is a separate question from conduct at work. An employer retains a statutory duty to provide a safe working environment, and can require employees to be fit for duty.
How should safety-critical roles be treated differently?
Roles involving machinery, driving, working at height or similar hazards can carry a stricter standard, provided the policy identifies those roles and records the operational reason. Asserting that a role is safety-critical without explaining why is the weak point.
Is this article legal advice?
No. It is general information. Employment law turns on specific facts, so have any policy reviewed by a South African labour lawyer before relying on it.
The bottom line on a workplace cannabis policy
A workplace cannabis policy earns its place by being specific. The version that fails is the one-line ban that treats every role the same, treats a metabolite as proof of impairment, and has nothing to say about an employee holding a valid prescription. The version that holds up states its safety purpose, grades roles honestly, explains what testing can and cannot show, and gives someone on a prescribed medicine a confidential route that leads to a fitness assessment rather than to the door. If your policy predates 2024, the most useful thing you can do this quarter is read it again against the Enever reasoning and have a labour lawyer mark it up.
Sources and references
- De Rebus, the journal of the Law Society of South Africa, on the Labour Appeal Court judgment in Enever v Barloworld Equipment South Africa and its implications for workplace cannabis policies: Balancing workplace safety and privacy (De Rebus)
- Occupational Health and Safety Act 85 of 1993, Government Gazette 14918, 2 July 1993 (the employer duty to provide a working environment that is safe and without risk to health, so far as is reasonably practicable): Act 85 of 1993 (gov.za, PDF)
- Minister of Justice and Constitutional Development and Others v Prince and Others, Constitutional Court of South Africa, 2018: Prince judgment (Constitutional Court collections)
- Cannabis for Private Purposes Act 7 of 2024, Government Gazette 50744, 3 June 2024: Act 7 of 2024 (Parliament of South Africa, PDF)
- Medicines and Related Substances Act 101 of 1965, as published in Government Gazette Extraordinary, 7 July 1965 (the Act under which section 21 authorisation is granted): Act 101 of 1965 (gov.za, PDF)
- South African Health Products Regulatory Authority, section 21 access to unregistered medicines: SAHPRA section 21
Want to see how legal access works in South Africa?
If you are an adult researching the prescriber-led route for yourself, you can create a Professor Green account and explore the store-access process. Registering is a first step, not a prescription, an eligibility decision or a guarantee that any product is available, and it has no bearing on any employment matter.
Register for Professor Green Store Access

